NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype
Open Access
- 8 September 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Abstract
Metastasis remains the cause of over 90% of cancer-related deaths. Cells undergoing metastasis use phenotypic plasticity to adapt to their changing environmental conditions and avoid therapy and immune response. Reversible transitions between epithelial and mesenchymal phenotypes – epithelial–mesenchymal transition (EMT) and its reverse mesenchymal–epithelial transition (MET) – form a key axis of phenotypic plasticity during metastasis and therapy resistance. Recent studies have shown that the cells undergoing EMT/MET can attain one or more hybrid epithelial/mesenchymal (E/M) phenotypes, the process of which is termed as partial EMT/MET. Cells in hybrid E/M phenotype(s) can be more aggressive than those in either epithelial or mesenchymal state. Thus, it is crucial to identify the factors and regulatory networks enabling such hybrid E/M phenotypes. Here, employing an integrated computational-experimental approach, we show that the transcription factor nuclear factor of activated T-cell (NFATc) can inhibit the process of complete EMT, thus stabilizing the hybrid E/M phenotype. It increases the range of parameters enabling the existence of a hybrid E/M phenotype, thus behaving as a phenotypic stability factor (PSF). However, unlike previously identified PSFs, it does not increase the mean residence time of the cells in hybrid E/M phenotypes, as shown by stochastic simulations; rather it enables the co-existence of epithelial, mesenchymal and hybrid E/M phenotypes and transitions among them. Clinical data suggests the effect of NFATc on patient survival in a tissue-specific or context-dependent manner. Together, our results indicate that NFATc behaves as a non-canonical PSF for a hybrid E/M phenotype.Keywords
All Related Versions
Funding Information
- Anusandhan National Research Foundation
This publication has 51 references indexed in Scilit:
- Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generationProceedings of the National Academy of Sciences, 2013
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitionsCell Cycle, 2011
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer CellsCell, 2011
- Nfatc1 Coordinates Valve Endocardial Cell Lineage Development Required for Heart Valve FormationCirculation Research, 2011
- Cellular Decision Making and Biological Noise: From Microbes to MammalsCell, 2011
- E-cadherin, β-catenin, and ZEB1 in malignant progression of cancerCancer and Metastasis Reviews, 2009
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- The calcineurin/NFAT signaling pathway: A NOVEL therapeutic target in leukemia and solid tumorsCell Cycle, 2008
- Cancer Metastasis: Building a FrameworkCell, 2006